Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Kogenate Bayer approved in E.U. for hemophilia A

Aug. 9, 2000

New serine protease inhibitors useful for thromboembolic disorders

Aug. 8, 2000

Once-daily postoperative dosing approved for Fragmin

Aug. 8, 2000

New benzene derivatives useful for pulmonary thrombosis

Aug. 7, 2000

New compounds under development at AstraZeneca for treatment of thrombosis

Aug. 7, 2000

Boehringer Ingelheim claims new antithrombotic compounds

Aug. 4, 2000

Dalteparin reduces risk of clotting after hip replacement surgery

Aug. 4, 2000

New Roche compounds inhibit amidolytic activity of factor VIIa/tissue factor complex

Aug. 1, 2000

TxA2 antagonism and antiplatelet effects of new torasemide derivative BM-531

July 28, 2000

Rapid thrombolysis without reocclusion following acute bolus administration of novel modified t-PA

July 24, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...